Mentions
Extended reach
Total likes
Video views
AI synopsis
Various posts express strong support and enthusiasm for the publication, with phrases like 'a great paper' and 'finally out' indicating interest. Several posts detail the findings, such as the high costs and mortality rates associated with resistant infections, which shows active engagement and acknowledgment of the publication's relevance. The tone and choice of words highlight the importance of this research in addressing critical health issues in LMICs, emphasizing its potential to influence healthcare policies and strategies.
Most discussions agree that the publication highlights serious issues related to antibiotic-resistant bloodstream infections in LMICs, emphasizing its importance.
The posts demonstrate high interest by mentioning detailed data, such as increased mortality, costs, and hospital stays, indicating curiosity about the research findings.
Many comments reference the methodology and specific statistics, showing a moderate level of deep engagement with the content.
The discussions suggest that the publication is perceived to have a significant impact on understanding global health challenges and might influence future infection control strategies.
Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infections caused by AMR bacteria in LMICs https://t.co/fBPlcZt1JT @LSHTM @LSHTM_AMR @UCLIGHE
Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis https://t.co/sVX21kLxxs Excess direct medical costs ~ $12,442 for ARB vs ASB BSI / patient, avg cost $41,103 due to premature mortality @kasim_allel et al https://t.co/2cE1fYyoiY
In a systematic review and meta-analysis, Kasim Allel and colleagues explore the impact of bloodstream infections caused by antibiotic-resistant bacteria: https://t.co/6tk4v9uys1 @kasim_allel @catmoore_1 @eundurra @passingship @LSHTM @LSHTM_AMR @UCLIGHE @microb_r https://t.co/wxm5L9lXgF
Drug-resistant bacterial bloodstream infections in LMICs: statistically significant higher mortality and costs. Systematic review and meta-analysis: https://t.co/J4lIolGc0u. Most of this data is from middle-income countries.
Kasim Allel and colleagues systematically review published literature from low- and middle-income countries and meta-analyse data extracted from 109 articles to explore the impact of bloodstream infections caused by antibiotic-resistant bacteria. https://t.co/6tk4v9v6hz https://t.co/VaHWFFP6nV
#Resources The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries (@kasim_allel) https://t.co/SrSdlSN2hE
This study highlights the significant health and economic impacts of bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries, including higher mortality, ICU admissions, and…
RT @PLOSMedicine: In a systematic review and meta-analysis, Kasim Allel and colleagues explore the impact of bloodstream infections caused…
RT @PLOSMedicine: In a systematic review and meta-analysis, Kasim Allel and colleagues explore the impact of bloodstream infections caused…
RT @PLOSMedicine: In a systematic review and meta-analysis, Kasim Allel and colleagues explore the impact of bloodstream infections caused…
RT @PLOSMedicine: In a systematic review and meta-analysis, Kasim Allel and colleagues explore the impact of bloodstream infections caused…
In a systematic review and meta-analysis, Kasim Allel and colleagues explore the impact of bloodstream infections caused by antibiotic-resistant bacteria: https://t.co/6tk4v9uys1 @kasim_allel @catmoore_1 @eundurra @passingship @LSHTM @LSHTM_AMR @UCLIGHE @microb_r https://t.co/wxm5L9lXgF
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
RT @koutterson: Drug-resistant bacterial bloodstream infections in LMICs: statistically significant higher mortality and costs. Systematic…
Drug-resistant bacterial bloodstream infections in LMICs: statistically significant higher mortality and costs. Systematic review and meta-analysis: https://t.co/J4lIolGc0u. Most of this data is from middle-income countries.
#PLOSMedicine: The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- ... https://t.co/PdgVp830mc Another great paper from @kasim_allel PhD
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis #science #publication #research #publications https://t.co/0hfqECH3o7
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis https://t.co/EQ0mv092HB
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
RT @DrDianeAshiru: Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis…
Impact of inpatient bloodstream infections by antibiotic-resistant bacteria in LMICs: systematic review & meta-analysis https://t.co/sVX21kLxxs Excess direct medical costs ~ $12,442 for ARB vs ASB BSI / patient, avg cost $41,103 due to premature mortality @kasim_allel et al https://t.co/2cE1fYyoiY
#Resources The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries (@kasim_allel) https://t.co/SrSdlSNA7c
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
#Resources The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries (@kasim_allel) https://t.co/SrSdlSN2hE
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
#Resources The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries (@kasim_allel) https://t.co/SrSdlSNA7c
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
RT @kasim_allel: Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infe…
Finally out. I am very pleased to share this article with you all. #PLOSMedicine: The impact of inpatient bloodstream infections caused by AMR bacteria in LMICs https://t.co/fBPlcZt1JT @LSHTM @LSHTM_AMR @UCLIGHE
Kasim Allel and colleagues systematically review published literature from low- and middle-income countries and meta-analyse data extracted from 109 articles to explore the impact of bloodstream infections caused by antibiotic-resistant bacteria. https://t.co/6tk4v9v6hz https://t.co/VaHWFFP6nV